Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Terminated 3Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 7CNS 5Sarcoma 4Other hematologic neoplasm 4Classical hematology 4Tumor-Agnostic 3Genitourinary 3Gynecologic 2Gastrointestinal 2Dermatologic 2Myeloid 1Head & Neck 1Endocrine 1

Conditions

Bone Neoplasms 2Sarcoma 1Osteosarcoma 1Hemorrhage 1

Interventions

Radiotherapy 137Cyclophosphamide 132Temozolomide 116Doxorubicin 99Filgrastim 68Ifosfamide 64Gemcitabine 58Etoposide 55Bevacizumab 51Imatinib Mesylate 50fludarabine phosphate 49Irinotecan 46pembrolizumab 45Peripheral Blood Stem Cell Transplantation 45pazopanib 43Magnetic Resonance Spectroscopy 42Methotrexate 40Carboplatin 40Busulfan 40Vincristine 38Surgical Procedures, Operative 37Nivolumab 37Melphalan 37Cisplatin 36Radiation 34Blood Specimen Collection 33Mycophenolic Acid 31Cyclosporine 31Docetaxel 29Trabectedin 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Tranexamic Acid × Sarcoma × Clear all
NCT04347122 2025-05-21

Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction

University of Kansas Medical Center

Phase 4 Terminated
12 enrolled 6 charts
Sarcoma

Sarcoma

NCT04410042 2024-12-20

Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure

St. Jude Children's Research Hospital

Phase 3 Terminated
15 enrolled 13 charts
Sarcoma

Bone Neoplasms

NCT05024253 2024-02-07

Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.

Children's Cancer Hospital Egypt 57357

Phase 3 Completed
48 enrolled
Sarcoma

Osteosarcoma

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated
56 enrolled
Sarcoma

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡